SAN DIEGO, June 28 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced the promotion of Lucile Blaise to President of Sleep & Respiratory Care, effective July 1, 2022. Blaise, currently ResMed’s Vice President of Sleep & Respiratory Care for Western Europe, is a medtech industry thought leader with over 25 years’ experience in [...]
SAN DIEGO and HILDESHEIM, Germany, June 14 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced a definitive agreement to acquire privately held MEDIFOX DAN, a German leader in out-of-hospital software solutions for providers in major settings across the care continuum, from Hg, a leading software and services investor. MEDIFOX DAN’s clinical, financial, and [...]
SAN DIEGO, May 25 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, June 1, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight Time) at the New York Hilton Midtown in New York City. More [...]
SAN FRANCISCO, May 18 (Korea Bizwire) — Sleep apnea sufferers can gain health benefits from PAP (positive airway pressure) treatment in as little as two hours per night, according to a study led by ResMed (NYSE: RMD, ASX: RMD) and presented at the American Thoracic Society’s annual International Conference. The retrospective, observational study analyzed the [...]
SAN DIEGO, May 5 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced that Jim Hollingshead, President, Sleep and Respiratory Care, has informed ResMed that he has accepted a new position and is leaving the company, effective immediately. Rob Douglas, President and Chief Operating Officer, has been appointed interim President, Sleep and Respiratory Care. [...]
SAN DIEGO, April 28 (Korea Bizwire) — ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2022. Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com Third Quarter 2022 Highlights All comparisons are to the prior year period Revenue increased by 12% to [...]
SAN DIEGO, April 27 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Tuesday, May 3, 2022, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time) via video webcast. More information about this event, including access to the live webcast, [...]
SAN DIEGO, April 7 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on Thursday, April 28, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. [...]
SAN DIEGO, March 17 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight Time) via webcast. More information about [...]
SAN DIEGO, March 14 (Korea Bizwire) — ResMed announced today the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year,1 asked nearly 25,000 respondents in 12 countries what’s keeping them up at night [...]